Back
ESC Premium Access

A polymethoxy flavonoid, Nobiletin, Has a therapeutic potency against the development of heart failure through NBP1 activation.

Session: Poster Session 2 - Heart failure: pathophysiology
Topic: Heart Failure
Speaker: Mr Y. Sunagawa (Shizuoka, JP)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Mr Yoichi Sunagawa

University of Shizuoka, Shizuoka (Japan)
0 follower

11 more presentations in this session

Polymorphic variants rs6684209 and rs7521023 of the calsequestrin 2 gene as risk factors for adverse course of heart failure

Speaker: Miss E. Muslimova (Tomsk, RU)

Access
Abstract
Slides
Like
Thumbnail

Association of granulocyte neprilysin (CD10) expression with prognosis in heart failure with reduced ejection fraction

Speaker: Doctor H. Arfsten (Vienna, AT)

Access
Abstract
Like
Thumbnail

m6A RNA-methylation in the progression of heart failure

Speaker: Mr E. Buchholz (Gottingen, DE)

Access
Abstract
Like
Thumbnail

Cancer drugs induce functional and structural impairment in adult cardiomyocytes.

Speaker: Doctor C. Altomare (Bellinzona, CH)

Access
Abstract
Like
Thumbnail

Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice

Speaker: Doctor Y. Obata (Sapporo, JP)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 2 - Heart failure: pathophysiology

Speakers: Mr Y. Sunagawa, Miss E. Muslimova, Doctor H. Arfsten, Mr E. Buchholz, Doctor C. Altomare...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources